nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—HRH1—atherosclerosis	0.956	1	CbGaD
Emedastine—Endophthalmitis—Pravastatin—atherosclerosis	0.00307	0.0733	CcSEcCtD
Emedastine—Olanzapine—HRH1—atherosclerosis	0.00222	0.812	CrCbGaD
Emedastine—Eye irritation—Lovastatin—atherosclerosis	0.00202	0.0483	CcSEcCtD
Emedastine—Sinusitis—Rosuvastatin—atherosclerosis	0.00107	0.0256	CcSEcCtD
Emedastine—Rhinitis—Rosuvastatin—atherosclerosis	0.00103	0.0245	CcSEcCtD
Emedastine—Sinusitis—Lovastatin—atherosclerosis	0.000906	0.0217	CcSEcCtD
Emedastine—Mental disorder—Rosuvastatin—atherosclerosis	0.000896	0.0214	CcSEcCtD
Emedastine—Sinusitis—Ezetimibe—atherosclerosis	0.000888	0.0212	CcSEcCtD
Emedastine—Sinusitis—Simvastatin—atherosclerosis	0.000847	0.0203	CcSEcCtD
Emedastine—Sinusitis—Pravastatin—atherosclerosis	0.000766	0.0183	CcSEcCtD
Emedastine—Rhinitis—Niacin—atherosclerosis	0.000746	0.0179	CcSEcCtD
Emedastine—Mental disorder—Ezetimibe—atherosclerosis	0.000745	0.0178	CcSEcCtD
Emedastine—Dysgeusia—Lovastatin—atherosclerosis	0.000739	0.0177	CcSEcCtD
Emedastine—Rhinitis—Pravastatin—atherosclerosis	0.000735	0.0176	CcSEcCtD
Emedastine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000713	0.017	CcSEcCtD
Emedastine—Vision blurred—Lovastatin—atherosclerosis	0.000711	0.017	CcSEcCtD
Emedastine—Mental disorder—Simvastatin—atherosclerosis	0.00071	0.017	CcSEcCtD
Emedastine—Eye disorder—Niacin—atherosclerosis	0.000696	0.0166	CcSEcCtD
Emedastine—Dysgeusia—Simvastatin—atherosclerosis	0.000691	0.0165	CcSEcCtD
Emedastine—Cardiac disorder—Pravastatin—atherosclerosis	0.00068	0.0163	CcSEcCtD
Emedastine—Vision blurred—Simvastatin—atherosclerosis	0.000665	0.0159	CcSEcCtD
Emedastine—Discomfort—Lovastatin—atherosclerosis	0.000635	0.0152	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000626	0.015	CcSEcCtD
Emedastine—Dysgeusia—Pravastatin—atherosclerosis	0.000625	0.0149	CcSEcCtD
Emedastine—Discomfort—Ezetimibe—atherosclerosis	0.000623	0.0149	CcSEcCtD
Emedastine—Pain—Rosuvastatin—atherosclerosis	0.000621	0.0149	CcSEcCtD
Emedastine—Vision blurred—Niacin—atherosclerosis	0.000611	0.0146	CcSEcCtD
Emedastine—Vision blurred—Pravastatin—atherosclerosis	0.000601	0.0144	CcSEcCtD
Emedastine—Discomfort—Simvastatin—atherosclerosis	0.000594	0.0142	CcSEcCtD
Emedastine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000592	0.0142	CcSEcCtD
Emedastine—Skin disorder—Ezetimibe—atherosclerosis	0.000587	0.014	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000548	0.0131	CcSEcCtD
Emedastine—Discomfort—Pravastatin—atherosclerosis	0.000537	0.0128	CcSEcCtD
Emedastine—Pain—Lovastatin—atherosclerosis	0.000527	0.0126	CcSEcCtD
Emedastine—Asthenia—Rosuvastatin—atherosclerosis	0.000521	0.0125	CcSEcCtD
Emedastine—Pain—Ezetimibe—atherosclerosis	0.000517	0.0124	CcSEcCtD
Emedastine—Tachycardia—Niacin—atherosclerosis	0.000516	0.0123	CcSEcCtD
Emedastine—Pruritus—Rosuvastatin—atherosclerosis	0.000514	0.0123	CcSEcCtD
Emedastine—Skin disorder—Niacin—atherosclerosis	0.000514	0.0123	CcSEcCtD
Emedastine—Olanzapine—ALB—atherosclerosis	0.000513	0.188	CrCbGaD
Emedastine—Pain—Simvastatin—atherosclerosis	0.000493	0.0118	CcSEcCtD
Emedastine—Rash—Rosuvastatin—atherosclerosis	0.000458	0.011	CcSEcCtD
Emedastine—Dermatitis—Rosuvastatin—atherosclerosis	0.000458	0.0109	CcSEcCtD
Emedastine—Headache—Rosuvastatin—atherosclerosis	0.000455	0.0109	CcSEcCtD
Emedastine—Pain—Niacin—atherosclerosis	0.000452	0.0108	CcSEcCtD
Emedastine—Pain—Pravastatin—atherosclerosis	0.000445	0.0107	CcSEcCtD
Emedastine—Asthenia—Lovastatin—atherosclerosis	0.000442	0.0106	CcSEcCtD
Emedastine—Pruritus—Lovastatin—atherosclerosis	0.000436	0.0104	CcSEcCtD
Emedastine—Asthenia—Ezetimibe—atherosclerosis	0.000433	0.0104	CcSEcCtD
Emedastine—Pruritus—Ezetimibe—atherosclerosis	0.000427	0.0102	CcSEcCtD
Emedastine—Asthenia—Simvastatin—atherosclerosis	0.000413	0.00988	CcSEcCtD
Emedastine—Pruritus—Simvastatin—atherosclerosis	0.000408	0.00975	CcSEcCtD
Emedastine—Rash—Lovastatin—atherosclerosis	0.000388	0.00929	CcSEcCtD
Emedastine—Dermatitis—Lovastatin—atherosclerosis	0.000388	0.00928	CcSEcCtD
Emedastine—Headache—Lovastatin—atherosclerosis	0.000386	0.00923	CcSEcCtD
Emedastine—Rash—Ezetimibe—atherosclerosis	0.000381	0.00911	CcSEcCtD
Emedastine—Dermatitis—Ezetimibe—atherosclerosis	0.00038	0.0091	CcSEcCtD
Emedastine—Asthenia—Niacin—atherosclerosis	0.000379	0.00908	CcSEcCtD
Emedastine—Headache—Ezetimibe—atherosclerosis	0.000378	0.00905	CcSEcCtD
Emedastine—Pruritus—Niacin—atherosclerosis	0.000374	0.00895	CcSEcCtD
Emedastine—Asthenia—Pravastatin—atherosclerosis	0.000374	0.00894	CcSEcCtD
Emedastine—Pruritus—Pravastatin—atherosclerosis	0.000368	0.00881	CcSEcCtD
Emedastine—Rash—Simvastatin—atherosclerosis	0.000363	0.00869	CcSEcCtD
Emedastine—Dermatitis—Simvastatin—atherosclerosis	0.000363	0.00868	CcSEcCtD
Emedastine—Headache—Simvastatin—atherosclerosis	0.000361	0.00863	CcSEcCtD
Emedastine—Rash—Niacin—atherosclerosis	0.000333	0.00798	CcSEcCtD
Emedastine—Dermatitis—Niacin—atherosclerosis	0.000333	0.00797	CcSEcCtD
Emedastine—Headache—Niacin—atherosclerosis	0.000331	0.00792	CcSEcCtD
Emedastine—Rash—Pravastatin—atherosclerosis	0.000328	0.00785	CcSEcCtD
Emedastine—Dermatitis—Pravastatin—atherosclerosis	0.000328	0.00785	CcSEcCtD
Emedastine—Headache—Pravastatin—atherosclerosis	0.000326	0.0078	CcSEcCtD
